Skip to main content
. Author manuscript; available in PMC: 2022 Mar 12.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2021 Jul 4;21(11):e895–e902. doi: 10.1016/j.clml.2021.06.022

Table 4:

Complete Remission Rates by Disease Subtype

Responses N=137 %
Complete Remission (CR+CRi) 117 85
Pre-B ALL 106 89
 Ph+ ALL 23 82
T-cell 11 65
Primary Refractory 19 14
Early Death (< 4 weeks) 1 1

Abbreviations: Pre-B = Precursor B; Ph = Philadelphia chromosome